| Date Filed | Type | Description |
| 07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/12/2023 |
4
| Mercier Johanna (Chief Commercial Officer) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Paid exercise price by delivering 1,272 shares
@ $78.12, valued at
$99.4k
Exercised 2,730 restricted stock units
@ $0 |
|
| 05/19/2023 |
4
| Mercier Johanna (Director) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Granted 4,290 options to buy
@ $95.27, valued at
$408.7k
Granted 2,100 restricted stock units
@ $0 |
|
| 03/13/2023 |
4
| Mercier Johanna (Chief Commercial Officer) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Paid exercise price by delivering 5,116 shares
@ $79.5, valued at
$406.7k
Exercised 3,025 restricted stock units
@ $0
Exercised 7,951 restricted stock units
@ $0
Granted 16,350 restricted stock units
@ $0
Granted 74,565 options to buy
@ $79.5, valued at
$5.9M
|
|
| 01/26/2023 |
4
| Mercier Johanna (Chief Commercial Officer) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Granted 29,124 shares
@ $0
Granted 38,270 shares
@ $0
Paid exercise price by delivering 15,325 shares
@ $84.02, valued at
$1.3M
|
|
| 12/13/2022 |
4
| Mercier Johanna (Chief Commercial Officer) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Paid exercise price by delivering 463 shares
@ $87.97, valued at
$40.7k
Exercised 990 restricted stock units
@ $0 |
|
| 09/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/28/2022 |
4
| Mercier Johanna (Chief Commercial Officer) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Granted 18,630 shares
@ $0 |
|
| 07/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/16/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/12/2021 |
4
| Mercier Johanna (Chief Commercial Officer) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Paid exercise price by delivering 1,435 shares
@ $63.91, valued at
$91.7k
Exercised 3,025 restricted stock units
@ $0
Granted 92,205 options to buy
@ $63.91, valued at
$5.9M
Granted 15,845 restricted stock units
@ $0 |
|
| 01/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/05/2020 |
4
| Mercier Johanna (Chief Commercial Officer) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Granted 26,270 shares
@ $0
Paid exercise price by delivering 12,282 shares
@ $58.83, valued at
$722.6k
|
|
| 07/28/2020 |
4
| Mercier Johanna (Chief Commercial Officer) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Paid exercise price by delivering 3,587 shares
@ $73.64, valued at
$264.1k
Exercised 7,505 restricted stock units
@ $0 |
|
| 03/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/26/2019 |
4
| Mercier Johanna (Chief Commercial Officer) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Granted 148,110 options to buy
@ $66.64, valued at
$9.9M
Granted 30,020 restricted stock units
@ $0 |
|
| 07/10/2019 |
3
| Mercier Johanna (Chief Commercial Officer) has filed a Form 3 on GILEAD SCIENCES INC |